产品名称 | NebuSelect™ Recombinant Mouse MMP-9, His-tag |
---|---|
目录号 | NBL-241733 |
别名 | MMP-9 |
外观 | see COA |
分子量 | Ala20-Pro730 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P41245 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241733-100ug | 100ug | Inquire | Inquire | |
NBL-241733-1mg | 1mg | Inquire | Inquire | |
NBL-241733-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse MMP-9, His-tag
Catalog#:
NBL-241733
Description:
NebuSelect™ Recombinant Mouse MMP-9, His-tag(Cat#NBL-241733) is expressed in HEK293 with His tag at the C-Terminus. The protein needs to be activated by APMA to have hydrolytic activity.It contains Ala20-Pro730.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 79.64 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Target Name:
MMP-9
Target Information:
Matrix metalloproteinase 9 (MMP9) contributes to this process and deficiencies in the MMP9 lead to impaired healing. Inappropriate expression of MMP9 also contributes to impaired re-epithelialization. Previously we demonstrated that FOXO1 was activated in wound healing but to higher levels in diabetic wounds. To address mechanisms of impaired re-epithelialization we examined MMP9 expression in vivo in full thickness dermal scalp wounds created in experimental K14.
Amino Acid Sequence:
Ala20-Pro730
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.